ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates Press release Annual General Meeting of Shareholders to be held on June 30, 2022René Beukema joins management team as Chief Corporate Development Officer and General Counsel and is nominated to Management BoardGerard Platenburg to assume Chief Scientific Officer role, with le June 01, 2022
ProQR Appoints John Maraganore, PhD, as Strategic Advisor to the Supervisory Board Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. March 07, 2022
ProQR Appoints Theresa Heggie as Chief Commercial Officer Press release Senior leader with extensive global rare disease commercialization experience Top-line data from Phase 2/3 pivotal Illuminate trial of sepofarsen for CEP290-mediated LCA10 on track for H1 2022 October 04, 2021